GlassScriptPhysician profile
Federico A Steiner
NPI 1598828527
$24,625.39
in general payments reported to CMS, 2019-2025
21 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $14.99 · 2021: $58.52 · 2022: $20.81 · 2023: $99.37 · 2024: $14K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $15K · Travel and Lodging: $6,857 · Food and Beverage: $2,166 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,500.00 |
| Travel and Lodging | $6,856.58 |
| Food and Beverage | $2,166.37 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,037.83 | 2024-2025 | |
| On Target Laboratories, INC | $5,842.04 | 2024-2025 | Cytalux |
| Stryker Corporation | $4,503.63 | 2023-2025 | 1788 |
| Davol INC. | $361.76 | 2019-2025 | Channel Drain, Progel Applicator Spray Tips |
| Edwards Lifesciences Corporation | $168.38 | 2024 | Inspiris Resilia Aortic Valve |
| Ethicon US, LLC | $91.93 | 2025 | Echelon Flex, Vistaseal, Evarrest |
| Astrazeneca Pharmaceuticals LP | $91.46 | 2019-2025 | Tagrisso |
| Galvanize Therapeutics, INC | $90.99 | 2024-2025 | Aliya System |
| Atricure, INC. | $82.33 | 2024 | |
| Zimmer Biomet Holdings, INC. | $56.95 | 2021-2023 | Ribfix Blu Advantage |
| Lexington Medical, INC. | $53.55 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Becton, Dickinson and Company | $48.17 | 2024 | Channel Drain |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $38.43 | 2024 | |
| Merck Sharp & Dohme LLC | $37.57 | 2019-2025 | Keytruda |
| E.R. Squibb & Sons, L.L.C. | $28.12 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20.81 | 2022 | |
| Ethicon INC. | $20.39 | 2021 | |
| Foundation Medicine, INC. | $15.61 | 2019 | |
| Genentech USA, INC. | $13.14 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.65 | 2019 | |
| Kls-Martin L.P. | $10.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Federico Steiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.